For years, “fasting bloodwork” was treated as the serious version of a cholesterol test.
No breakfast. Morning appointment. Water only. Then, presumably, a more trustworthy answer.
That assumption is being examined more closely. A 2025 UK laboratory consensus statement and recent international reviews reflect a broader shift toward allowing nonfasting lipid panels in many routine settings. At the same time, fasting still matters in some circumstances. The useful question is not whether fasting is good or bad. It is: what does the sample represent, and what question is the test being asked to answer? ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/39789723/?utm_source=openai))
What a lipid panel actually measures
A standard lipid panel reports concentrations of several blood lipids or lipoprotein-related measures at the time blood is drawn. These commonly include total cholesterol, HDL cholesterol, triglycerides, and LDL cholesterol. Non-HDL cholesterol can be calculated by subtracting HDL cholesterol from total cholesterol.
This is a measurement of what is circulating in a blood sample. It is not a direct measurement of plaque in arteries. It is not a diagnosis. And it is not a complete account of cardiovascular risk, which also depends on factors a lipid panel does not measure.
LDL cholesterol deserves an additional footnote. Depending on the laboratory and the triglyceride level, LDL may be measured directly or estimated with a calculation. That distinction can matter because high triglycerides can make some LDL calculations less reliable.
What eating changes, and what it usually does not
Food does not affect every component of a lipid panel equally.
Triglycerides tend to be the most meal-sensitive part of the standard panel. They can rise after eating, with the amount and timing of that change varying by the meal, the individual, alcohol intake, metabolic state, recent activity, illness, and ordinary biological variation.
Total cholesterol, HDL cholesterol, and many measures used for overall risk assessment generally change much less after usual food intake. This is why major cardiology guidance recognizes either fasting or nonfasting lipid profiles as useful for estimating cardiovascular risk in many adults. ([professional.heart.org](https://professional.heart.org/en/-/media/PHD-Files-2/Science-News/2/2018/2018_aha_acc_aacvpr_aapa_abc_acpm_ada_ags_apha_aspc_nla_pcna_guideline_on_the_management_of_blood?utm_source=openai))
But “changes less” is not the same as “never changes.” A nonfasting result is not interchangeable with a fasting result in every situation, and a fasting result is not automatically more clinically meaningful simply because it required more preparation.
Why the disagreement is not a contradiction
Recent literature does not offer one tidy conclusion that applies to every purpose of testing.
A 2024 review in Clinical Chemistry described growing international adoption of nonfasting lipid testing and concluded that normal food intake produces relatively small changes in most lipid and lipoprotein measures. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/38646857/?utm_source=openai))
But a 2024 systematic review and meta-analysis reached a more cautious conclusion, arguing that fasting provides greater consistency and less variability for routine lipid testing. Its finding does not prove that nonfasting tests are useless. It highlights a different priority: when the goal is to make repeated results easier to compare, controlling one variable, recent food intake, can be useful. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/38937752/?utm_source=openai))
Both ideas can be true. A nonfasting panel can be informative. A fasting panel can sometimes offer a more standardized comparison. The right interpretation depends on why the measurement was obtained and what result is being considered.
When fasting may add important context
Fasting is often more relevant when triglycerides are substantially elevated on a nonfasting sample, when LDL cholesterol needs a more dependable baseline calculation, or when triglycerides themselves are the central question.
The 2018 American Heart Association and American College of Cardiology cholesterol guidance states that an initial fasting or nonfasting lipid profile can estimate risk and document baseline LDL cholesterol. It also advises repeating the panel in a fasting state when nonfasting triglycerides are 400 mg/dL or higher. ([professional.heart.org](https://professional.heart.org/en/-/media/PHD-Files-2/Science-News/2/2018/2018_aha_acc_aacvpr_aapa_abc_acpm_ada_ags_apha_aspc_nla_pcna_guideline_on_the_management_of_blood?utm_source=openai))
That is not a rule that fasting proves the first result was wrong. It is a recognition that a follow-up measurement under more controlled conditions may clarify what the triglyceride result represents.
The comparison problem people often miss
A common interpretation mistake is comparing two numbers as though they came from identical circumstances.
One lipid panel may have been drawn after an overnight fast. Another may have been drawn after breakfast, a poor night of sleep, an acute illness, a strenuous workout, a celebratory weekend, or a medication change. The numbers may differ. But the difference does not automatically reveal a meaningful biological change.
This is the broader laboratory-literacy point: a result includes both the person and the conditions of collection.
Fasting status is one pre-analytic variable. Time of day, recent alcohol use, illness, laboratory method, and whether LDL was calculated or directly measured can also shape interpretation. A trend is most useful when the testing conditions and methods are known, not when every result is assumed to be a clean before-and-after story.
A better question than “Should I have fasted?”
Rather than treating fasting as a pass-or-fail requirement, it may be more useful to ask:
- Was this sample fasting or nonfasting?
- Which lipid values are most likely to be influenced by that distinction?
- Was LDL measured or calculated?
- Is this result being compared with one collected under similar conditions?
- What decision or question is this panel meant to inform?
More standardized testing can sometimes reduce noise. More convenient testing can sometimes make useful information easier to obtain. Neither approach eliminates uncertainty.
A lipid panel is a snapshot, not a verdict. Fasting changes the frame around that snapshot. It does not turn laboratory data into certainty.
Written for Dr. Teralyn Sell, PhD
Psychology · Brain Health · Human Behavior
Sources worth knowing
- Standardising lipid testing and reporting in the United Kingdom; a joint statement by HEART UK and The Association for Laboratory Medicine
- Worldwide Increasing Use of Nonfasting Rather Than Fasting Lipid Profiles
- Unraveling the controversy between fasting and nonfasting lipid testing in a normal population: a systematic review and meta-analysis of 244,665 participants
- 2018 Guideline on the Management of Blood Cholesterol: Slide Set